Us Bancorp \De\ Citius Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

  • $77.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.79 - $1.28 $7,900 - $12,800
-10,000 Reduced 83.33%
2,000 $1,000
Q3 2021

Nov 10, 2021
BUY
$1.74 - $2.6 $1,740 - $2,600
1,000 Added 9.09%
12,000 $24,000
Q1 2021

Apr 28, 2021
BUY
$1.04 - $2.34 $1,040 - $2,340
1,000 Added 10.0%
11,000 $20,000
Q3 2020

Nov 10, 2020
BUY
$0.83 - $1.51 $8,300 - $15,100
10,000 New
10,000 $10,000

Others Institutions Holding CTXR

# of Institutions
61
Shares Held
23.7M
Call Options Held
83.1K
Put Options Held
32.1K
View Full List

About Citius Pharmaceuticals, Inc.

CTXR Quotes by TradingView
  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $378M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email